Publication:
Long term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinoma

dc.contributor.authorKim, W. R.
dc.contributor.authorBerg, Thomas
dc.contributor.authorLoomba, Rohit
dc.contributor.authorSchall, Raul Aguilar
dc.contributor.authorDinh, Phillip
dc.contributor.authorYee, Leland J.
dc.contributor.authorMartins, Eduardo B.
dc.contributor.authorFlaherty, John F.
dc.contributor.authorButi, Maria
dc.contributor.authorMarcellin, P.
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.date.accessioned2022-11-18T08:12:20Z
dc.date.available2022-11-18T08:12:20Z
dc.date.issued2013-04
dc.identifier.citationKim, W. R. vd. (2013). "Long term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinoma". Journal of Hepatology, 58, Supplement 1, S19-S19.
dc.identifier.endpageS19
dc.identifier.issn0168-8278
dc.identifier.startpageS19
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(13)60045-8
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0168827813600458
dc.identifier.urihttp://hdl.handle.net/11452/29479
dc.identifier.volume58, Supplement 1
dc.identifier.wos000322983000044
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt dışı
dc.relation.journalJournal of Hepatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastroenterology & hepatology
dc.subject.wosGastroenterology & hepatology
dc.titleLong term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinoma
dc.typeMeeting Abstract
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: